Early pregnancy protein multiplex screening reflects circulating and urinary divergences associated with the development of preeclampsia
Background: Preeclampsia, a pregnancy disorder characterized by hypertension and proteinuria, represents the leading cause of fetal and maternal morbidity and mortality in developing countries. The identification of novel and accurate biomarkers that are predictive of preeclampsia is necessary to im...
Saved in:
Published in | Hypertension in pregnancy Vol. 37; no. 1; pp. 37 - 50 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
02.01.2018
Taylor & Francis Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: Preeclampsia, a pregnancy disorder characterized by hypertension and proteinuria, represents the leading cause of fetal and maternal morbidity and mortality in developing countries. The identification of novel and accurate biomarkers that are predictive of preeclampsia is necessary to improve the prognosis of patients with preeclampsia.
Objective: To evaluate the preeclampsia predictive value of 34 angiogenic-related proteins.
Methods: We performed a nested cohort case-control study of pregnant women. The profile of the 34 proteins was evaluated at 12, 16, and 20 gestational weeks (GWs), using urine/plasma from 16 women who developed preeclampsia and 20 normotensive pregnant controls by Bio-Plex Pro
TM
Human Cancer Biomarker Panels 1 and 2.
Results: The urine concentration of soluble epidermal growth factor receptor (sEGFR), hepatocyte growth factor (HGF), angiopoietin-2 (ANG-2), endoglin (ENG), soluble fas ligand (sFASL), interleukin 6 (IL-6), placental growth factor (PLGF), and vascular endothelial growth factor A (VEGF-A) at 12 GW, prolactin (PRL), ANG-2, transforming growth factor alpha (TGF-α), and VEGF-A at 16 GW, and soluble IL-6 receptor alpha (sIL-6Rα), ANG-2 and sFASL at 20 GW, were different between groups (p < 0.05). The concentration cut-off values calculated in this study for the mentioned proteins, predicted an increased risk to developing preeclampsia in a range of 3.8-29.8 times in the study population.
Conclusion: The proteins sEGFR, HGF, ANG-2, sFASL, IL-6, PLGF, VEGF-A, PRL, TGF-α FGF-b, sHER2/Neu sIL-6Rα, ENG, uPA, and insulin-like growth factor binding protein 1 (IGFBP-1), were predictive of the development of preeclampsia and their use as markers for this disease should be considered. |
---|---|
AbstractList | Background: Preeclampsia, a pregnancy disorder characterized by hypertension and proteinuria, represents the leading cause of fetal and maternal morbidity and mortality in developing countries. The identification of novel and accurate biomarkers that are predictive of preeclampsia is necessary to improve the prognosis of patients with preeclampsia. Objective: To evaluate the preeclampsia predictive value of 34 angiogenic-related proteins. Methods: We performed a nested cohort case-control study of pregnant women. The profile of the 34 proteins was evaluated at 12, 16, and 20 gestational weeks (GWs), using urine/plasma from 16 women who developed preeclampsia and 20 normotensive pregnant controls by Bio-Plex ProTM Human Cancer Biomarker Panels 1 and 2. Results: The urine concentration of soluble epidermal growth factor receptor (sEGFR), hepatocyte growth factor (HGF), angiopoietin-2 (ANG-2), endoglin (ENG), soluble fas ligand (sFASL), interleukin 6 (IL-6), placental growth factor (PLGF), and vascular endothelial growth factor A (VEGF-A) at 12 GW, prolactin (PRL), ANG-2, transforming growth factor alpha (TGF-α), and VEGF-A at 16 GW, and soluble IL-6 receptor alpha (sIL-6Rα), ANG-2 and sFASL at 20 GW, were different between groups (p < 0.05). The concentration cut-off values calculated in this study for the mentioned proteins, predicted an increased risk to developing preeclampsia in a range of 3.8–29.8 times in the study population. Conclusion: The proteins sEGFR, HGF, ANG-2, sFASL, IL-6, PLGF, VEGF-A, PRL, TGF-α FGF-b, sHER2/Neu sIL-6Rα, ENG, uPA, and insulin-like growth factor binding protein 1 (IGFBP-1), were predictive of the development of preeclampsia and their use as markers for this disease should be considered. Preeclampsia, a pregnancy disorder characterized by hypertension and proteinuria, represents the leading cause of fetal and maternal morbidity and mortality in developing countries. The identification of novel and accurate biomarkers that are predictive of preeclampsia is necessary to improve the prognosis of patients with preeclampsia. To evaluate the preeclampsia predictive value of 34 angiogenic-related proteins. We performed a nested cohort case-control study of pregnant women. The profile of the 34 proteins was evaluated at 12, 16, and 20 gestational weeks (GWs), using urine/plasma from 16 women who developed preeclampsia and 20 normotensive pregnant controls by Bio-Plex Pro Human Cancer Biomarker Panels 1 and 2. The urine concentration of soluble epidermal growth factor receptor (sEGFR), hepatocyte growth factor (HGF), angiopoietin-2 (ANG-2), endoglin (ENG), soluble fas ligand (sFASL), interleukin 6 (IL-6), placental growth factor (PLGF), and vascular endothelial growth factor A (VEGF-A) at 12 GW, prolactin (PRL), ANG-2, transforming growth factor alpha (TGF-α), and VEGF-A at 16 GW, and soluble IL-6 receptor alpha (sIL-6Rα), ANG-2 and sFASL at 20 GW, were different between groups (p < 0.05). The concentration cut-off values calculated in this study for the mentioned proteins, predicted an increased risk to developing preeclampsia in a range of 3.8-29.8 times in the study population. The proteins sEGFR, HGF, ANG-2, sFASL, IL-6, PLGF, VEGF-A, PRL, TGF-α FGF-b, sHER2/Neu sIL-6Rα, ENG, uPA, and insulin-like growth factor binding protein 1 (IGFBP-1), were predictive of the development of preeclampsia and their use as markers for this disease should be considered. BACKGROUNDPreeclampsia, a pregnancy disorder characterized by hypertension and proteinuria, represents the leading cause of fetal and maternal morbidity and mortality in developing countries. The identification of novel and accurate biomarkers that are predictive of preeclampsia is necessary to improve the prognosis of patients with preeclampsia.OBJECTIVETo evaluate the preeclampsia predictive value of 34 angiogenic-related proteins.METHODSWe performed a nested cohort case-control study of pregnant women. The profile of the 34 proteins was evaluated at 12, 16, and 20 gestational weeks (GWs), using urine/plasma from 16 women who developed preeclampsia and 20 normotensive pregnant controls by Bio-Plex ProTM Human Cancer Biomarker Panels 1 and 2.RESULTSThe urine concentration of soluble epidermal growth factor receptor (sEGFR), hepatocyte growth factor (HGF), angiopoietin-2 (ANG-2), endoglin (ENG), soluble fas ligand (sFASL), interleukin 6 (IL-6), placental growth factor (PLGF), and vascular endothelial growth factor A (VEGF-A) at 12 GW, prolactin (PRL), ANG-2, transforming growth factor alpha (TGF-α), and VEGF-A at 16 GW, and soluble IL-6 receptor alpha (sIL-6Rα), ANG-2 and sFASL at 20 GW, were different between groups (p < 0.05). The concentration cut-off values calculated in this study for the mentioned proteins, predicted an increased risk to developing preeclampsia in a range of 3.8-29.8 times in the study population.CONCLUSIONThe proteins sEGFR, HGF, ANG-2, sFASL, IL-6, PLGF, VEGF-A, PRL, TGF-α FGF-b, sHER2/Neu sIL-6Rα, ENG, uPA, and insulin-like growth factor binding protein 1 (IGFBP-1), were predictive of the development of preeclampsia and their use as markers for this disease should be considered. Background: Preeclampsia, a pregnancy disorder characterized by hypertension and proteinuria, represents the leading cause of fetal and maternal morbidity and mortality in developing countries. The identification of novel and accurate biomarkers that are predictive of preeclampsia is necessary to improve the prognosis of patients with preeclampsia. Objective: To evaluate the preeclampsia predictive value of 34 angiogenic-related proteins. Methods: We performed a nested cohort case-control study of pregnant women. The profile of the 34 proteins was evaluated at 12, 16, and 20 gestational weeks (GWs), using urine/plasma from 16 women who developed preeclampsia and 20 normotensive pregnant controls by Bio-Plex Pro TM Human Cancer Biomarker Panels 1 and 2. Results: The urine concentration of soluble epidermal growth factor receptor (sEGFR), hepatocyte growth factor (HGF), angiopoietin-2 (ANG-2), endoglin (ENG), soluble fas ligand (sFASL), interleukin 6 (IL-6), placental growth factor (PLGF), and vascular endothelial growth factor A (VEGF-A) at 12 GW, prolactin (PRL), ANG-2, transforming growth factor alpha (TGF-α), and VEGF-A at 16 GW, and soluble IL-6 receptor alpha (sIL-6Rα), ANG-2 and sFASL at 20 GW, were different between groups (p < 0.05). The concentration cut-off values calculated in this study for the mentioned proteins, predicted an increased risk to developing preeclampsia in a range of 3.8-29.8 times in the study population. Conclusion: The proteins sEGFR, HGF, ANG-2, sFASL, IL-6, PLGF, VEGF-A, PRL, TGF-α FGF-b, sHER2/Neu sIL-6Rα, ENG, uPA, and insulin-like growth factor binding protein 1 (IGFBP-1), were predictive of the development of preeclampsia and their use as markers for this disease should be considered. |
Author | Trejo-Vázquez, Fabiola Ortiz-Castro, Yolanda Castruita-De La Rosa, Claudia Ortiz-Rodriguez, Jose M Martinez-Fierro, Margarita L Delgado-Enciso, Ivan Cid-Baez, Miguel A Sotelo-Ham, Elma I Castañeda-Lopez, Maria E Cardiel-Hernandez, Rosa M Castañeda-Miranda, Rodrigo Espinoza-Juarez, Marcela A Garza-Veloz, Idalia Solis-Sanchez, Luis O Aviles, Angelica Garcia Cardenas-Vargas, Edith |
Author_xml | – sequence: 1 givenname: Margarita L orcidid: 0000-0003-1478-9068 surname: Martinez-Fierro fullname: Martinez-Fierro, Margarita L email: margaritamf@uaz.edu.mx organization: Centro de Innovacion Tecnologica e Industrial, Unidad Academica de Ingenieria Electrica. Universidad Autonoma de Zacatecas – sequence: 2 givenname: Claudia surname: Castruita-De La Rosa fullname: Castruita-De La Rosa, Claudia organization: Molecular Medicine Laboratory, Unidad Academica de Medicina Humana y Ciencias de la Salud, Universidad Autonoma de Zacatecas – sequence: 3 givenname: Idalia orcidid: 0000-0002-6307-1696 surname: Garza-Veloz fullname: Garza-Veloz, Idalia organization: Centro de Innovacion Tecnologica e Industrial, Unidad Academica de Ingenieria Electrica. Universidad Autonoma de Zacatecas – sequence: 4 givenname: Rosa M surname: Cardiel-Hernandez fullname: Cardiel-Hernandez, Rosa M organization: Molecular Medicine Laboratory, Unidad Academica de Medicina Humana y Ciencias de la Salud, Universidad Autonoma de Zacatecas – sequence: 5 givenname: Marcela A orcidid: 0000-0001-9644-0382 surname: Espinoza-Juarez fullname: Espinoza-Juarez, Marcela A organization: Molecular Medicine Laboratory, Unidad Academica de Medicina Humana y Ciencias de la Salud, Universidad Autonoma de Zacatecas – sequence: 6 givenname: Ivan orcidid: 0000-0001-9848-862X surname: Delgado-Enciso fullname: Delgado-Enciso, Ivan organization: Instituto Estatal de Cancerologia, Servicios de Salud del Estado de Colima – sequence: 7 givenname: Maria E surname: Castañeda-Lopez fullname: Castañeda-Lopez, Maria E organization: Molecular Medicine Laboratory, Unidad Academica de Medicina Humana y Ciencias de la Salud, Universidad Autonoma de Zacatecas – sequence: 8 givenname: Edith orcidid: 0000-0001-5353-0441 surname: Cardenas-Vargas fullname: Cardenas-Vargas, Edith organization: Hospital General Zacatecas "Luz González Cosío", Servicios de Salud de Zacatecas – sequence: 9 givenname: Fabiola surname: Trejo-Vázquez fullname: Trejo-Vázquez, Fabiola organization: Molecular Medicine Laboratory, Unidad Academica de Medicina Humana y Ciencias de la Salud, Universidad Autonoma de Zacatecas – sequence: 10 givenname: Elma I surname: Sotelo-Ham fullname: Sotelo-Ham, Elma I organization: Coordinacion de Investigacion Estatal de la Secretaría de Salud de Zacatecas, Servicios de Salud de Zacatecas – sequence: 11 givenname: Rodrigo orcidid: 0000-0003-4938-9179 surname: Castañeda-Miranda fullname: Castañeda-Miranda, Rodrigo organization: Centro de Innovacion Tecnologica e Industrial, Unidad Academica de Ingenieria Electrica. Universidad Autonoma de Zacatecas – sequence: 12 givenname: Miguel A orcidid: 0000-0001-7918-0072 surname: Cid-Baez fullname: Cid-Baez, Miguel A organization: Centro de Innovacion Tecnologica e Industrial, Unidad Academica de Ingenieria Electrica. Universidad Autonoma de Zacatecas – sequence: 13 givenname: Jose M orcidid: 0000-0002-8199-8401 surname: Ortiz-Rodriguez fullname: Ortiz-Rodriguez, Jose M organization: Centro de Innovacion Tecnologica e Industrial, Unidad Academica de Ingenieria Electrica. Universidad Autonoma de Zacatecas – sequence: 14 givenname: Luis O orcidid: 0000-0003-2545-4116 surname: Solis-Sanchez fullname: Solis-Sanchez, Luis O organization: Centro de Innovacion Tecnologica e Industrial, Unidad Academica de Ingenieria Electrica. Universidad Autonoma de Zacatecas – sequence: 15 givenname: Angelica Garcia surname: Aviles fullname: Aviles, Angelica Garcia organization: Hospital General Zacatecas "Luz González Cosío", Servicios de Salud de Zacatecas – sequence: 16 givenname: Yolanda orcidid: 0000-0002-7555-0213 surname: Ortiz-Castro fullname: Ortiz-Castro, Yolanda organization: Molecular Medicine Laboratory, Unidad Academica de Medicina Humana y Ciencias de la Salud, Universidad Autonoma de Zacatecas |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29308696$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1u1DAUhSNURH_gEUBespnBTuwk3oGqQitVYgNr68a-mbpy7GA7becNeGyczrRLVr46-u451j3n1YkPHqvqI6NbRnv6hdGWMynEtqas2zLOmOTtm-qMiVpsWtqKkzIXZrNCp9V5Sve0kJyLd9VpLRvat7I9q_5eQXR7MkfcefB6nUJG68m0uGxnh08k6Yjord-RiKNDnRPRNurFQV5F8IYs0XqIe2LsA8Ydeo2JQEpBW8hoyKPNdyTfITH4gC7ME_pMwrimonYwzcnC--rtCC7hh-N7Uf3-fvXr8npz-_PHzeW3243mTZ03HMFoAXTskXWMjyOaooiuxpEBcE4H3XaD0NC1euA1GwwV2DYgZQtNI2VzUd0cfE2AezVHO5WPqwBWPQsh7hTEbLVDVeumKymNQd7xmsMwdnJgtcZiD4L3xevzwasc7c-CKavJJo3OgcewJMVkLwvXsTVWHFAdQ0rlkK_RjKq1UPVSqFoLVcdCy96nY8QyTGhet14aLMDXA2D9GOIEjyE6ozLsXYhjLJXapJr_Z_wDVgC1-A |
CitedBy_id | crossref_primary_10_3389_fphar_2021_663044 crossref_primary_10_1080_00365513_2018_1516892 crossref_primary_10_20883_medical_e984 crossref_primary_10_3390_ijms241612842 crossref_primary_10_4081_ejh_2022_3429 crossref_primary_10_1080_14767058_2019_1597046 crossref_primary_10_1097_HJH_0000000000001808 crossref_primary_10_1684_ecn_2020_0443 crossref_primary_10_1097_AOG_0000000000004171 crossref_primary_10_3390_ijerph18137045 crossref_primary_10_1016_j_ejogrb_2019_05_036 crossref_primary_10_3390_cells10051003 crossref_primary_10_1016_j_preghy_2020_05_003 crossref_primary_10_1016_j_ejogrb_2023_03_012 crossref_primary_10_1371_journal_pone_0267826 |
Cites_doi | 10.1210/jc.2008-0305 10.1083/jcb.60.2.423 10.1081/PRG-120016790 10.1016/j.ijcard.2014.10.168 10.1371/journal.pone.0063368 10.1002/pd.4811 10.3109/10641955.2013.853777 10.3109/00365519209088393 10.1155/2016/3027363 10.1002/uog.13439 10.1001/jama.293.1.77 10.1016/j.placenta.2014.12.006 10.1093/nar/gku989 10.1016/S0014-4827(03)00089-2 10.3109/14767058.2012.722710 10.1002/pd.2660 10.1155/2011/481095 10.1159/000341264 10.1172/JCI17189 10.3109/10641955.2013.798332 10.1073/pnas.1706546114 10.3109/14767050903366119 10.1002/prca.201400092 10.1161/HYPERTENSIONAHA.110.164285 10.1155/2012/481520 10.1177/1358836X0100600406 10.1038/sj.ki.5000075 10.1111/j.1540-8159.1987.tb04516.x 10.1016/j.ejogrb.2012.10.011 10.3892/etm.2015.2280 10.1016/j.medici.2016.11.008 10.5468/ogs.2015.58.1.10 10.1016/j.placenta.2014.07.001 10.1515/CCLM.2004.026 10.3109/10641950109152635 10.1016/0378-4274(92)90205-X 10.1186/s12884-015-0608-y 10.3109/10641955.2013.827203 10.1080/10641955.2016.1218502 10.1371/journal.pone.0091923 10.1074/jbc.C300012200 10.18869/acadpub.ibj.21.5.312 10.1161/HYPERTENSIONAHA.111.00754 10.1080/10641955.2017.1291673 10.1002/uog.7628 10.1681/ASN.2006090956 10.1016/j.semnephrol.2004.07.008 |
ContentType | Journal Article |
Copyright | 2018 Taylor & Francis 2018 |
Copyright_xml | – notice: 2018 Taylor & Francis 2018 |
DBID | NPM AAYXX CITATION 7X8 DOA |
DOI | 10.1080/10641955.2017.1411946 |
DatabaseName | PubMed CrossRef MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1525-6065 |
EndPage | 50 |
ExternalDocumentID | oai_doaj_org_article_2c37e173de47424abf79b12ce5caa548 10_1080_10641955_2017_1411946 29308696 1411946 |
Genre | Original Articles Journal Article |
GrantInformation_xml | – fundername: Consejo Nacional de Ciencia y Tecnología grantid: -FOMIX M0024-2013-01-203220; -INFR-254106 and 225520; -SALUD-2010-138721; -SALUD-2012-01-181124; -SEP-CB-2009-01-0128567; SEP-CB-2015-258316 funderid: 10.13039/501100007350 |
GroupedDBID | --- 00X 03L 0BK 0R~ 0YH 29I 36B 4.4 5GY 5RE AAJNR AALUX AAMIU AAPUL AAPXX AAQRR ABBKH ABDBF ABEIZ ABLKL ABPTK ABUPF ACENM ACFUF ACGEJ ACGFS ACLSK ADCVX ADFCX ADRBQ ADXPE AECIN AENEX AEOZL AEYQI AFKVX AFWLO AGDLA AGFJD AGRBW AIJEM AIRBT AJWEG AKBVH ALIIL ALMA_UNASSIGNED_HOLDINGS ALQZU AMDAE BABNJ BLEHA BOHLJ CCCUG CS3 DKSSO DU5 EAP EBC EBD EBS EJD EMB EMK EMOBN EPL ESX F5P H13 HZ~ J.N KRBQP KSSTO KWAYT KYCEM M4Z O9- P2P RNANH RVRKI SV3 TFDNU TFL TFW TUS UEQFS V1S ~1N .GJ 53G 5VS AALIY AAORF ABJNI ABLIJ ABWCV ABXYU ABZEW ACKZS ADFOM ADFZZ AEIIZ AFLEI AGYJP AI. AJVHN ALYBC AWYRJ BRMBE CAG COF CYYVM CZDIS DRXRE DWTOO GROUPED_DOAJ JENTW LJTGL M44 NPM NUSFT QQXMO TBQAZ TDBHL TERGH TUROJ VH1 ZXP AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c432t-4eadc5a0f8e1714ffedead572ef1aa440bc67b5ca76cb421bd05e63a996a33993 |
IEDL.DBID | DOA |
ISSN | 1064-1955 |
IngestDate | Fri Oct 04 13:11:01 EDT 2024 Fri Aug 16 20:39:47 EDT 2024 Fri Aug 23 04:55:49 EDT 2024 Sat Sep 28 08:51:19 EDT 2024 Tue Jun 13 19:53:49 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Angiogenesis screening urine biomarkers placenta cancer preeclampsia |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c432t-4eadc5a0f8e1714ffedead572ef1aa440bc67b5ca76cb421bd05e63a996a33993 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-2545-4116 0000-0002-8199-8401 0000-0002-6307-1696 0000-0003-4938-9179 0000-0002-7555-0213 0000-0001-9848-862X 0000-0001-9644-0382 0000-0001-7918-0072 0000-0003-1478-9068 0000-0001-5353-0441 |
OpenAccessLink | https://doaj.org/article/2c37e173de47424abf79b12ce5caa548 |
PMID | 29308696 |
PQID | 1989548719 |
PQPubID | 23479 |
PageCount | 14 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_2c37e173de47424abf79b12ce5caa548 proquest_miscellaneous_1989548719 crossref_primary_10_1080_10641955_2017_1411946 pubmed_primary_29308696 informaworld_taylorfrancis_310_1080_10641955_2017_1411946 |
PublicationCentury | 2000 |
PublicationDate | 2018-01-02 |
PublicationDateYYYYMMDD | 2018-01-02 |
PublicationDate_xml | – month: 01 year: 2018 text: 2018-01-02 day: 02 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Hypertension in pregnancy |
PublicationTitleAlternate | Hypertens Pregnancy |
PublicationYear | 2018 |
Publisher | Taylor & Francis Taylor & Francis Group |
Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Group |
References | CIT0030 CIT0032 CIT0031 CIT0034 CIT0036 CIT0035 CIT0038 CIT0037 Poon LC (CIT0016) 2010; 35 CIT0039 CIT0041 CIT0043 Almasry SM (CIT0033) 2016; 57 CIT0042 CIT0001 CIT0045 CIT0044 CIT0003 CIT0047 CIT0002 CIT0046 CIT0049 CIT0004 CIT0048 CIT0007 CIT0006 CIT0009 CIT0008 CIT0050 Kauma SW (CIT0026) 1999; 84 CIT0051 CIT0010 CIT0012 CIT0011 Garza-Veloz I (CIT0005) 2011; 11 Karakus S (CIT0040) CIT0014 CIT0013 CIT0015 CIT0018 CIT0017 CIT0019 CIT0021 CIT0020 CIT0023 CIT0022 CIT0025 CIT0024 CIT0027 CIT0029 CIT0028 |
References_xml | – ident: CIT0019 doi: 10.1210/jc.2008-0305 – ident: CIT0044 doi: 10.1083/jcb.60.2.423 – ident: CIT0034 doi: 10.1081/PRG-120016790 – ident: CIT0017 doi: 10.1016/j.ijcard.2014.10.168 – ident: CIT0022 doi: 10.1371/journal.pone.0063368 – ident: CIT0050 doi: 10.1002/pd.4811 – ident: CIT0006 doi: 10.3109/10641955.2013.853777 – ident: CIT0009 doi: 10.3109/00365519209088393 – ident: CIT0031 doi: 10.1155/2016/3027363 – volume: 84 start-page: 4092 year: 1999 ident: CIT0026 publication-title: J Clin Endocrinol Metab. contributor: fullname: Kauma SW – ident: CIT0039 doi: 10.1002/uog.13439 – ident: CIT0018 doi: 10.1001/jama.293.1.77 – ident: CIT0025 doi: 10.1016/j.placenta.2014.12.006 – ident: CIT0028 doi: 10.1093/nar/gku989 – ident: CIT0036 doi: 10.1016/S0014-4827(03)00089-2 – ident: CIT0030 doi: 10.3109/14767058.2012.722710 – ident: CIT0015 doi: 10.1002/pd.2660 – ident: CIT0001 doi: 10.1155/2011/481095 – ident: CIT0014 doi: 10.1159/000341264 – ident: CIT0013 doi: 10.1172/JCI17189 – ident: CIT0037 doi: 10.3109/10641955.2013.798332 – ident: CIT0038 doi: 10.1073/pnas.1706546114 – ident: CIT0043 doi: 10.3109/14767050903366119 – ident: CIT0004 doi: 10.1002/prca.201400092 – ident: CIT0010 doi: 10.1161/HYPERTENSIONAHA.110.164285 – ident: CIT0045 doi: 10.1155/2012/481520 – ident: CIT0046 doi: 10.1177/1358836X0100600406 – ident: CIT0049 doi: 10.1038/sj.ki.5000075 – ident: CIT0002 doi: 10.1111/j.1540-8159.1987.tb04516.x – ident: CIT0011 doi: 10.1016/j.ejogrb.2012.10.011 – ident: CIT0040 publication-title: Arch Gynecol Obstet. contributor: fullname: Karakus S – ident: CIT0027 doi: 10.3892/etm.2015.2280 – ident: CIT0032 doi: 10.1016/j.medici.2016.11.008 – ident: CIT0041 doi: 10.5468/ogs.2015.58.1.10 – ident: CIT0042 doi: 10.1016/j.placenta.2014.07.001 – ident: CIT0035 doi: 10.1515/CCLM.2004.026 – volume: 57 start-page: 681 year: 2016 ident: CIT0033 publication-title: Rom J Morphol Embryol. contributor: fullname: Almasry SM – volume: 11 start-page: 35 year: 2011 ident: CIT0005 publication-title: No association between polymorphisms/haplotypes of the vascular endothelial growth factor gene and preeclampsia. BMC Pregnancy Childbirth. contributor: fullname: Garza-Veloz I – ident: CIT0023 doi: 10.3109/10641950109152635 – ident: CIT0047 doi: 10.1016/0378-4274(92)90205-X – ident: CIT0048 doi: 10.1186/s12884-015-0608-y – ident: CIT0003 doi: 10.3109/10641955.2013.827203 – ident: CIT0024 doi: 10.1080/10641955.2016.1218502 – ident: CIT0007 doi: 10.1371/journal.pone.0091923 – ident: CIT0012 doi: 10.1074/jbc.C300012200 – ident: CIT0029 doi: 10.18869/acadpub.ibj.21.5.312 – ident: CIT0020 doi: 10.1161/HYPERTENSIONAHA.111.00754 – ident: CIT0051 doi: 10.1080/10641955.2017.1291673 – volume: 35 start-page: 662 year: 2010 ident: CIT0016 publication-title: Ultrasound Obstet Gynecol. doi: 10.1002/uog.7628 contributor: fullname: Poon LC – ident: CIT0021 doi: 10.1681/ASN.2006090956 – ident: CIT0008 doi: 10.1016/j.semnephrol.2004.07.008 |
SSID | ssj0017445 |
Score | 2.2682602 |
Snippet | Background: Preeclampsia, a pregnancy disorder characterized by hypertension and proteinuria, represents the leading cause of fetal and maternal morbidity and... Preeclampsia, a pregnancy disorder characterized by hypertension and proteinuria, represents the leading cause of fetal and maternal morbidity and mortality in... BACKGROUNDPreeclampsia, a pregnancy disorder characterized by hypertension and proteinuria, represents the leading cause of fetal and maternal morbidity and... |
SourceID | doaj proquest crossref pubmed informaworld |
SourceType | Open Website Aggregation Database Index Database Publisher |
StartPage | 37 |
SubjectTerms | Angiogenesis biomarkers cancer placenta preeclampsia screening urine |
Title | Early pregnancy protein multiplex screening reflects circulating and urinary divergences associated with the development of preeclampsia |
URI | https://www.tandfonline.com/doi/abs/10.1080/10641955.2017.1411946 https://www.ncbi.nlm.nih.gov/pubmed/29308696 https://search.proquest.com/docview/1989548719 https://doaj.org/article/2c37e173de47424abf79b12ce5caa548 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pb9UwDI7QkBAXNH6_AVOQuJY1bZqmxz3gaUIaJybtFjmOi3bpe3rvTYL_gD8bO23HQEK7cKusSrVi1_HnOJ-VekcIGOvoilhBLKxjuAM-UhFjcr2BMsVSLgqff3FnF_bzZXN5a9SX9ISN9MDjwp1UWLdk2jqRZRRnIfZtF02F1CAAp9s5-ppmBlPT-UFr83hixju2MF3TzHd3fHkiMhFJW1fLgcIwjHd_7EqZvP8v6tJ_J6B5I1odqkdTBqlPR80fq3s0PFEPzqcz8qfqZ-Ys1pstfRMyDXlay0hLPfcOftccKhi-8qalWROp2-80Xm0xT_JiIQxJSxEetj90kr6NTNi50zCZkpKW8q3m3FGn301Het3LVwnZyTa7K3imLlafvn44K6Z5CwXautoXlr0KGyh7TzIWve8psaRpK2KrgbVlRNdGXvfWYbSVialsyNXAkAlqSXSeq4NhPdBLpTlsoYcasPNok-182TviZMkmj53zuFDv5_UOm5FWI5iJrXQ2UBADhclAC7UUq9y8LKzYWcC-EiZfCXf5ykJ1t20a9rko0o8TTEJ9hwJvZwcI_AfKsQoMtL7eBek6E9xnuoV6MXrGjZqcTDFm7NzR_1D_lXrIGvlcAKpeq4P99precEq0j8fq_uny43J1nP-CXw5dCnc |
link.rule.ids | 315,786,790,870,2115,27957,27958 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Early+pregnancy+protein+multiplex+screening+reflects+circulating+and+urinary+divergences+associated+with+the+development+of+preeclampsia&rft.jtitle=Hypertension+in+pregnancy&rft.au=Margarita+L+Martinez-Fierro&rft.au=Claudia+Castruita-De+La+Rosa&rft.au=Idalia+Garza-Veloz&rft.au=Rosa+M+Cardiel-Hernandez&rft.date=2018-01-02&rft.pub=Taylor+%26+Francis+Group&rft.issn=1064-1955&rft.eissn=1525-6065&rft.volume=37&rft.issue=1&rft.spage=37&rft.epage=50&rft_id=info:doi/10.1080%2F10641955.2017.1411946&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_2c37e173de47424abf79b12ce5caa548 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1064-1955&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1064-1955&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1064-1955&client=summon |